Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Mar 26, 2007

Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets

Mar 23, 2007

Mylan Laboratories Launches Amlodipine Besylate Tablets and Has Triggered Its 180 Days of Exclusivity

Mar 14, 2007

Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets

Mar 02, 2007

Mylan Laboratories Announces Pricing of Senior Convertible Notes and Common Stock

Feb 28, 2007

Mylan Announces Launch of Quinapril Tablets, USP and Quinapril Hydrochloride and Hydrochlorothiazide Tablets

Feb 27, 2007

Mylan Provides an Update on Amlodipine Besylate Litigation

Feb 26, 2007

Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP

Feb 20, 2007

Mylan Laboratories Plans Registered Offering of Common Stock and Senior Convertible Notes

Feb 16, 2007

Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP

Feb 08, 2007

Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)

Pagination

First page
Previous page
…
Page 99
Page 100
Page 101
Page 102
Current page 103
Page 104
Page 105
Page 106
Page 107
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.